Pasithea Therapeutics Corp KTTA
$0.54 $0.07 (14.77%) 1D
Last Updated: Aug 21, 08:00 PM·NASDAQ
Pricing for US stocks is delayed by 24 hours
KTTA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Pasithea Therapeutics Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Pasithea Therapeutics Corp. Stock Analysis KTTA
United States Health Care Nano Cap Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company is headquartered in Miami Beach, Florida and currently employs 5 full-time employees. The company went IPO on 2021-08-13. The firm is advancing a pipeline of three therapeutic product candidates, with a focus on its lead product candidate, PAS-004, a macrocyclic mitogen-activated protein kinase, or MEK inhibitor. PAS-004 is a small molecule allosteric inhibitor of MEK 1 and 2 (MEK 1/2) for potential use in the treatment of a range of RASopathies, including neurofibromatosis type 1 (NF1) and a number of oncology indications, among others. Its remaining two programs, PAS-001 and PAS-003, are in the earlier stages of development and are based on novel targets for the treatment of CNS disorders that it believes address limitations in the treatment paradigm of the indications it plans to address, which are amyotrophic lateral sclerosis (ALS) for its PAS-003 program, and schizophrenia for its PAS-001 program.
Pasithea Therapeutics Corp (KTTA) Chart
Financial Metrics & Statements of Pasithea Therapeutics Corp (KTTA)
FAQ's for Pasithea Therapeutics Corp (KTTA)
- As of August 2026, Pasithea Therapeutics Corp KTTA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pasithea Therapeutics Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Pasithea Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Pasithea Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Pasithea Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Pasithea Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Pasithea Therapeutics Corp (KTTA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
